ICD 9 Range OTHER METABOLIC AND IMMUNITY DISORDERS

• 1  Disorders of amino-acid transport and metabolism     ( 270 )

• 2  Disturbances of amino-acid transport     ( 270.0 )

• 3   Phenylketonuria (PKU)     ( 270.1 )

• 4  Other disturbances of aromatic amino-acid metabolism     ( 270.2 )

• 5  Disturbances of branched-chain amino-acid metabolism     ( 270.3 )

• 6  Disturbances of sulphur-bearing amino-acid metabolism     ( 270.4 )

• 7  Disturbances of histidine metabolism     ( 270.5 )

• 8  Disorders of urea cycle metabolism     ( 270.6 )

• 9  Other disturbances of straight-chain amino-acid metabolism     ( 270.7 )

• 10  Other specified disorders of amino-acid metabolism     ( 270.8 )

• 11  Unspecified disorder of amino-acid metabolism     ( 270.9 )

• 12  Disorders of carbohydrate transport and metabolism     ( 271 )

• 13  Glycogenosis     ( 271.0 )

• 14  Galactosemia     ( 271.1 )

• 15  Hereditary fructose intolerance     ( 271.2 )

• 16  Intestinal disaccharidase deficiencies and disaccharide malabsorption     ( 271.3 )

• 17  Renal glycosuria     ( 271.4 )

• 18  Other specified disorders of carbohydrate transport and metabolism     ( 271.8 )

• 19  Unspecified disorder of carbohydrate transport and metabolism     ( 271.9 )

• 20  Disorders of lipoid metabolism     ( 272 )

• 21  Pure hypercholesterolemia     ( 272.0 )

• 22  Pure hyperglyceridemia     ( 272.1 )

• 23  Mixed hyperlipidemia     ( 272.2 )

• 24  Hyperchylomicronemia     ( 272.3 )

• 25  Other and unspecified hyperlipidemia     ( 272.4 )

• 26  Lipoprotein deficiencies     ( 272.5 )

• 27  Lipodystrophy     ( 272.6 )

• 28  Lipidoses     ( 272.7 )

• 29  Other disorders of lipoid metabolism     ( 272.8 )

• 30  Unspecified disorder of lipoid metabolism     ( 272.9 )

• 31  Disorders of plasma protein metabolism     ( 273 )

• 32  Polyclonal hypergammaglobulinemia     ( 273.0 )

• 33  Monoclonal paraproteinemia     ( 273.1 )

• 34  Other paraproteinemias     ( 273.2 )

• 35  Macroglobulinemia     ( 273.3 )

• 36  Alpha-1-antitrypsin deficiency     ( 273.4 )

• 37  Other disorders of plasma protein metabolism     ( 273.8 )

• 38  Unspecified disorder of plasma protein metabolism     ( 273.9 )

• 39  Gout     ( 274 )

• 40  Gouty arthropathy     ( 274.0 )

• 41  Acute gouty arthropathy     ( 274.01 )

• 42  Chronic gouty arthropathy without mention of tophus (tophi)     ( 274.02 )

• 43  Chronic gouty arthropathy with tophus (tophi)     ( 274.03 )

• 44  Gouty arthropathy, unspecified     ( 274.00 )

• 45  Gouty nephropathy     ( 274.1 )

• 46  Gouty nephropathy unspecified     ( 274.10 )

• 47  Uric acid nephrolithiasis     ( 274.11 )

• 48  Other gouty nephropathy     ( 274.19 )

• 49  Gout with other specified manifestations     ( 274.8 )

• 50  Gouty tophi of ear     ( 274.81 )

• 51  Gouty tophi of other sites except ear     ( 274.82 )

• 52  Gout with other specified manifestations     ( 274.89 )

• 53  Gout unspecified     ( 274.9 )

• 54  Disorders of mineral metabolism     ( 275 )

• 55  Disorders of iron metabolism     ( 275.0 )

• 56  Disorders of copper metabolism     ( 275.1 )

• 57  Disorders of magnesium metabolism     ( 275.2 )

• 58  Disorders of phosphorus metabolism     ( 275.3 )

• 59  Disorders of calcium metabolism     ( 275.4 )

• 60  Unspecified disorder of calcium metabolism     ( 275.40 )

• 61  Hypocalcemia     ( 275.41 )

• 62  Hypercalcemia     ( 275.42 )

• 63  Other disorders of calcium metabolism     ( 275.49 )

• 64  Hungry bone syndrome     ( 275.5 )

• 65  Other specified disorders of mineral metabolism     ( 275.8 )

• 66  Unspecified disorder of mineral metabolism     ( 275.9 )

• 67  Disorders of fluid electrolyte and acid-base balance     ( 276 )

• 68  Hyperosmolality and/or hypernatremia     ( 276.0 )

• 69  Hyposmolality and/or hyponatremia     ( 276.1 )

• 70  Acidosis     ( 276.2 )

• 71  Alkalosis     ( 276.3 )

• 72  Mixed acid-base balance disorder     ( 276.4 )

• 73  Volume depletion disorder     ( 276.5 )

• 74  Volume depletion, unspecified     ( 276.50 )

• 75  Dehydration     ( 276.51 )

• 76  Hypovolemia     ( 276.52 )

• 77  Fluid overload disorder     ( 276.6 )

• 78  Hyperpotassemia     ( 276.7 )

• 79  Hypopotassemia     ( 276.8 )

• 80  Electrolyte and fluid disorders not elsewhere classified     ( 276.9 )

• 81  Other and unspecified disorders of metabolism     ( 277 )

• 82  Cystic fibrosis     ( 277.0 )

• 83  Cystic fibrosis without meconium ileus     ( 277.00 )

• 84  Cystic fibrosis with meconium ileus     ( 277.01 )

• 85  Cystic fibrosis with pulmonary manifestations     ( 277.02 )

• 86  Cystic fibrosis with gastrointestinal manifestations     ( 277.03 )

• 87  Cystic fibrosis with other manifestations     ( 277.09 )

• 88  Disorders of porphyrin metabolism     ( 277.1 )

• 89  Other disorders of purine and pyrimidine metabolism     ( 277.2 )

• 90  Amyloidosis     ( 277.3 )

• 91  Amyloidosis, unspecified     ( 277.30 )

• 92  Familial mediterranean fever     ( 277.31 )

• 93  Other amyloidosis     ( 277.39 )

• 94  Disorders of bilirubin excretion     ( 277.4 )

• 95  Mucopolysaccharidosis     ( 277.5 )

• 96  Other deficiencies of circulating enzymes     ( 277.6 )

• 97  Dysmetabolic syndrome x     ( 277.7 )

• 98  Other specified disorders of metabolism     ( 277.8 )

• 99  Primary carnitine deficiency     ( 277.81 )

• 100  Carnitine deficiency due to inborn errors of metabolism     ( 277.82 )

• 101  Iatrogenic carnitine deficiency     ( 277.83 )

• 102  Other secondary carnitine deficiency     ( 277.84 )

• 103  Disorders of fatty acid oxidation     ( 277.85 )

• 104  Peroxisomal disorders     ( 277.86 )

• 105  Disorders of mitochondrial metabolism     ( 277.87 )

• 106  Other specified disorders of metabolism     ( 277.89 )

• 107  Tumor lysis syndrome     ( 277.88 )

• 108  Unspecified disorder of metabolism     ( 277.9 )

• 109  Obesity and other hyperalimentation     ( 278 )

• 110  Obesity     ( 278.0 )

• 111  Obesity unspecified     ( 278.00 )

• 112  Morbid obesity     ( 278.01 )

• 113  Overweight     ( 278.02 )

• 114  Localized adiposity     ( 278.1 )

• 115   Hypervitaminosis A     ( 278.2 )

• 116  Hypercarotinemia     ( 278.3 )

• 117   Hypervitaminosis D     ( 278.4 )

• 118  Other hyperalimentation     ( 278.8 )

• 119  Disorders involving the immune mechanism     ( 279 )

• 120  Deficiency of humoral immunity     ( 279.0 )

• 121  Hypogammaglobulinemia unspecified     ( 279.00 )

• 122   Selective IgA immunodeficiency     ( 279.01 )

• 123   Selective IgM immunodeficiency     ( 279.02 )

• 124  Other selective immunoglobulin deficiencies     ( 279.03 )

• 125  Congenital hypogammaglobulinemia     ( 279.04 )

• 126   Immunodeficiency with increased IgM     ( 279.05 )

• 127  Common variable immunodeficiency     ( 279.06 )

• 128  Other deficiency of humoral immunity     ( 279.09 )

• 129  Deficiency of cell-mediated immunity     ( 279.1 )

• 130   Immunodeficiency with predominant T-cell defect unspecified     ( 279.10 )

• 131  Digeorge's syndrome     ( 279.11 )

• 132  Wiskott-aldrich syndrome     ( 279.12 )

• 133  Nezelof's syndrome     ( 279.13 )

• 134  Other deficiency of cell-mediated immunity     ( 279.19 )

• 135  Combined immunity deficiency     ( 279.2 )

• 136  Unspecified immunity deficiency     ( 279.3 )

• 137  Autoimmune disease not elsewhere classified     ( 279.4 )

• 138  Autoimmune lymphoproliferative syndrome     ( 279.41 )

• 139  Autoimmune disease, not elsewhere classified     ( 279.49 )

• 140  Disorders involving the immune mechanism : Graft-versus-host disease     ( 279.5 )

• 141  Graft-versus-host disease, unspecified     ( 279.50 )

• 142  Acute graft-versus-host disease     ( 279.51 )

• 143  Chronic graft-versus-host disease     ( 279.52 )

• 144  Acute on chronic graft-versus-host disease     ( 279.53 )

• 145  Other specified disorders involving the immune mechanism     ( 279.8 )

• 146  Unspecified disorder of immune mechanism     ( 279.9 )

• 147  Hereditary hemochromatosis     ( 275.01 )

• 148  Hemochromatosis due to repeated red blood cell transfusions     ( 275.02 )

• 149  Other disorders of iron metabolism     ( 275.09 )

• 150  Other hemochromatosis     ( 275.03 )

• 151  Transfusion associated circulatory overload     ( 276.61 )

• 152  Other fluid overload     ( 276.69 )

• 153  Obesity hypoventilation syndrome     ( 278.03 )